Neuronostics
2 known investors
Neuronostics develops BioEP, software that applies digital analysis of background EEG to generate biomarkers supporting epilepsy diagnosis for clinicians and neurology services. The product aims to make epilepsy diagnostics more efficient and enable earlier, more accurate diagnoses.
AI & Machine LearningDigital HealthMedical Devices